BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Junaid A, Tang H, van Reeuwijk A, Abouleila Y, Wuelfroth P, van Duinen V, Stam W, van Zonneveld AJ, Hankemeier T, Mashaghi A. Ebola Hemorrhagic Shock Syndrome-on-a-Chip. iScience 2020;23:100765. [PMID: 31887664 DOI: 10.1016/j.isci.2019.100765] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Feaugas T, Sauvonnet N. Organ-on-chip to investigate host-pathogens interactions. Cell Microbiol 2021;23:e13336. [PMID: 33798273 DOI: 10.1111/cmi.13336] [Reference Citation Analysis]
2 Junaid A, van Duinen V, Stam W, Dólleman S, Yang W, de Rijke Y, Endeman H, van Kooten C, Mashaghi A, de Boer H, van Gils J, Hankemeier T, van Zonneveld AJ. A Microfluidics-Based Screening Tool to Assess the Impact of Blood Plasma Factors on Microvascular Integrity. Adv Biol (Weinh) 2021;5:e2100954. [PMID: 34590440 DOI: 10.1002/adbi.202100954] [Reference Citation Analysis]
3 Junaid A, Hankemeier T. OrganoPlate Micro-fluidic Microvessel Culture and Analysis. Bio Protoc 2021;11:e4070. [PMID: 34327267 DOI: 10.21769/BioProtoc.4070] [Reference Citation Analysis]
4 Yi HG, Kim H, Kwon J, Choi YJ, Jang J, Cho DW. Application of 3D bioprinting in the prevention and the therapy for human diseases. Signal Transduct Target Ther 2021;6:177. [PMID: 33986257 DOI: 10.1038/s41392-021-00566-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang H, Vreeken D, Junaid A, Wang G, Sol WMPJ, de Bruin RG, van Zonneveld AJ, van Gils JM. Endothelial Semaphorin 3F Maintains Endothelial Barrier Function and Inhibits Monocyte Migration. Int J Mol Sci 2020;21:E1471. [PMID: 32098168 DOI: 10.3390/ijms21041471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Eisa-Beygi S, Vo NJ, Link BA. RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis. Drug Discov Today 2021;26:1790-3. [PMID: 33358701 DOI: 10.1016/j.drudis.2020.12.012] [Reference Citation Analysis]
7 He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y. Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights. Front Immunol 2021;12:683879. [PMID: 34135911 DOI: 10.3389/fimmu.2021.683879] [Reference Citation Analysis]
8 Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res 2020;287:198108. [PMID: 32768490 DOI: 10.1016/j.virusres.2020.198108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
9 Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci 2020;250:117583. [PMID: 32217117 DOI: 10.1016/j.lfs.2020.117583] [Cited by in Crossref: 235] [Cited by in F6Publishing: 215] [Article Influence: 117.5] [Reference Citation Analysis]
10 Goldstein ME, Scull MA. Modeling Innate Antiviral Immunity in Physiological Context. J Mol Biol 2021;:167374. [PMID: 34863779 DOI: 10.1016/j.jmb.2021.167374] [Reference Citation Analysis]
11 Vlachou M, Siamidi A, Dedeloudi A, Konstantinidou SK, Papanastasiou IP. Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review). Int J Mol Med 2021;47:47. [PMID: 33576451 DOI: 10.3892/ijmm.2021.4880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Baddal B, Marrazzo P. Refining Host-Pathogen Interactions: Organ-on-Chip Side of the Coin. Pathogens 2021;10:203. [PMID: 33668558 DOI: 10.3390/pathogens10020203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Liu W, Tang D, Xu XX, Liu YJ, Jiu Y. How Physical Factors Coordinate Virus Infection: A Perspective From Mechanobiology. Front Bioeng Biotechnol 2021;9:764516. [PMID: 34778236 DOI: 10.3389/fbioe.2021.764516] [Reference Citation Analysis]
14 Zhang M, Wang P, Luo R, Wang Y, Li Z, Guo Y, Yao Y, Li M, Tao T, Chen W, Han J, Liu H, Cui K, Zhang X, Zheng Y, Qin J. Biomimetic Human Disease Model of SARS-CoV-2 Induced Lung Injury and Immune Responses on Organ Chip System. Adv Sci (Weinh) 2020;:2002928. [PMID: 33173719 DOI: 10.1002/advs.202002928] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
15 Wongchitrat P, Shukla M, Sharma R, Govitrapong P, Reiter RJ. Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection. Antioxidants (Basel) 2021;10:E47. [PMID: 33401749 DOI: 10.3390/antiox10010047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
16 Tang H, Abouleila Y, Mashaghi A. Lassa hemorrhagic shock syndrome-on-a-chip. Biotechnol Bioeng 2021;118:1405-10. [PMID: 33241859 DOI: 10.1002/bit.27636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tan DX, Hardeland R. Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19. Molecules 2020;25:E4410. [PMID: 32992875 DOI: 10.3390/molecules25194410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
18 Tang H, Abouleila Y, Si L, Ortega-Prieto AM, Mummery CL, Ingber DE, Mashaghi A. Human Organs-on-Chips for Virology. Trends Microbiol 2020;28:934-46. [PMID: 32674988 DOI: 10.1016/j.tim.2020.06.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
19 Romero A, Ramos E, López-Muñoz F, Gil-Martín E, Escames G, Reiter RJ. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? Cell Mol Neurobiol 2020. [PMID: 32772307 DOI: 10.1007/s10571-020-00938-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
20 El-Missiry MA, El-Missiry ZMA, Othman AI. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19. Eur J Pharmacol 2020;882:173329. [PMID: 32615182 DOI: 10.1016/j.ejphar.2020.173329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
21 Parlakpinar H, Polat S, Acet HA. Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin. Fundam Clin Pharmacol 2021;35:62-75. [PMID: 32657483 DOI: 10.1111/fcp.12589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Wang Y, Wang P, Qin J. Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases. Acc Chem Res 2021;54:3550-62. [PMID: 34459199 DOI: 10.1021/acs.accounts.1c00411] [Reference Citation Analysis]